Vera Therapeutics, Inc. (VERA) saw its stock soar 5.08% in intraday trading on Thursday, driven by a series of analyst updates and the company's announcement of its participation in an upcoming healthcare conference.
Wedbush adjusted its price target on Vera Therapeutics' stock from $38 to $34 while maintaining a Neutral rating. Additionally, other analysts provided insights and ratings on the company, potentially influencing investor sentiment.
Furthermore, Vera Therapeutics announced that its management team will participate in a fireside chat and one-on-one investor meetings at the TD Cowen 45th Annual Health Care Conference, scheduled for March 3-5, 2025. This upcoming event presentation may have generated interest among investors and contributed to the stock's upward movement.
Comments